DRKS00017896CompletedNot Applicable
Predictors of psoriasis on response to systemic therapy - PREDICT
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 381
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18 Years to one (—)
- Sex
- All
Inclusion Criteria
- •Adult patients (= 18 years) with moderate to severe plaque psoriasis (defined by the European Consensus 2011 [5]) and present indication for conventional systemic psoriasis treatment (fumaric acid ester, MTX, cyclosporine, etc.) who are naive (untreated) to conventional psoriasis system therapy at the time of initiation of observation.
Exclusion Criteria
- •Patients who have already been treated with systemic psoriasis medications, i.e. are not naive to systemic psoriasis therapy and/or patients who are receiving PUVA therapy and/or patients who cannot or do not wish to sign the informed consent form
Investigators
Similar Trials
Active, not recruiting
Phase 1
Study in patients with moderate to severe psoriasis with secukinumabEUCTR2014-002212-16-DEovartis Pharma GmbH
Unknown
Not Applicable
Cross-sectional Evaluation of Biological Markers of Cardiovascular Disease in Children and Adolescents With PsoriasisPsoriasisCardiovascular RiskInflammationObesityNCT01122095University of California, San Diego100
Completed
Not Applicable
Impact of the symptoms of psoriasis on QoL and work productivitypsoriasisJPRN-UMIN000008295osaka university dermatology150
Completed
Not Applicable
Epigenetic biomarkers to predict psoriasis disease progression * towards tailored therapy.psoriasisskin disease with fast proliferation and less differentiation of skin cells1004078910011063NL-OMON40335Maastricht Universitair Medisch Centrum +9
Recruiting
Not Applicable
Investigation of the stress burden of psoriasis patients before and under a modern biologic treatmentPsoriasis vulgarisL40.0DRKS00023751niversitätsklinikum Essen (AöR), Klinik für Dermatologie, Venerologie und Allergologie100